First Congress of VITARES, Veterinary Immunotherapy and Translational Research
27 February to 1 March, 2019

Luigi Aurisicchio
Vitares is excited to host The first Italian One Health meeting focusing on Cancer Immunotherapy

Follow




Download Brochure

Welcome!

Dear Friends and Colleagues,
I am pleased to announce the First Congress of VITARES, Veterinary Immunotherapy and Translational Research which will take place from 27 February to 1 March 2019 at Castel Romano, Rome.

Public health initiatives such as One Health demonstrate the growing awareness of the fact that animal and human health are strongly interconnected with each other and with the environment. Zoonotic pathogens and Cancer represent a direct hazard to Veterinary and Human Health. This meeting brings together Basic research, Veterinary and Human Medicine Scientists involved in the field of Immunology, Oncology and Education, aiming at creating networks of collaboration. Internationally renowned scientists from Italy and abroad will provide the State of the Art and present their most recent data in a highly stimulating scientific environment.

Topics will range from the importance of Preclinical Models for Basic and Applied Science, Veterinary and Human Oncology and Immunologic therapies side by side and the impact of Environment. Furthermore, a discussion will take place on some of the most current aspects and societal implications of the Translational Medicine.

We are sure that you will enjoy very much this exciting Congress and look forward to meeting you in Rome.

Luigi Aurisicchio
VITARES President

Final Program

Day 1 February 27th 2019
  • 9.00-10.00  Registration

Session 1 – Promoting One Health Approach

  • 9.30 Introduction and Conference Objectives, Luigi Aurisicchio (VITARES, Rome, Italy)
  • 9,40 SPERA: le Ragioni della Ricerca, Annarita Wirz (SPERA and Fondazione S. Lucia, Rome, Italy)
  • 10,00 The Importance of Scientific journalism and correct communication, Enrica Battifoglia (ANSA, Italy)
  • 10.20 VITARES Magazine for One Health, Erika Salvatori (Evvivax, Rome, Italy)
  • 10.40 Research and development of immunotherapeutic drugs in Veterinary and Comparative Oncology, Paolo Pasquali (Istituto Superiore di Sanità, Roma)
  • 11,10 Preclinical safety of vaccines- the point of view of the CRO, Isabella Andreini (Research Toxicology Center, Pomezia)
  • 11.30 Coffee Break

Session 2 – Preclinical models for Cancer Immunotherapy
Chairperson: Luigi Aurisicchio

  • 12.00 The Importance of Preclinical Models for Cancer Research, Luigi Aurisicchio (VITARES, Rome, Italy)
  • 12.40 Modelling cancer immunotherapy in mice: the prostate cancer lesson, Matteo Bellone (Ospedale San Raffaele, Milan and NIBIT, Italy)
  • 13.30 Lunch Break
  • 14.30 Of Mice and Zebrafish: shedding light for Oncology Research, Giulia Piaggio (Istituto Regina Elena, Roma, Italy)
  • 15.00 T regulatory cells and Immunosuppression in cancer: evidences in preclinical models, Silvia Piconese (La Sapienza University, Rome, Italy)
  • 15,40 Neoantigen Cancer Vaccines, Fabio Palombo (Takis Biotech, Rome)
  • 16.20 Adoptive CAR T cells: from conception to clinical trials, Concetta Quintarelli (Ospedale Pediatrico Bambin Gesù, Rome, Italy)
  • 17.00 Preclinical Models and Drug development, Rita De Santis (Alfasigma, Pomezia, Italy)
  • 17.30 Overview of global One Health initiatives", Cheryl Stroud, DVM, PhD Executive Director (One Health Commission, USA) via Skype
  • 18.00  End of Day 1

Final Program

Day 2 February 28th 2019

Session 3- New treatments in Veterinary Oncology
Chairperson: Luigi Aurisicchio

  • 9.00 Unleashing Canine Comparative Oncology, Federica Cavallo (University of Turin, Italy)
  • 9.40 Electrochemotherapy: experience at the University of Pisa, Petra Simčič (University of Pisa, Italy)
  • 10.10 Etiology and Clinical features of K9 Lymphoma, Alessandra Gavazza (University of Camerino, Italy)
  • 10.50 Break
  • 11.15 Safety and Efficacy of Electrochemotherapy: our experience in Rome, Daniela Mignacca (Clinica Veterinaria Roma Sud, Roma)
  • 11.45 Electro-Chemo-Immuno Therapy: activating local and systemic immunity, Luigi Aurisicchio (VITARES, Rome, Italy)
  • 12.15 New approaches in Veterinary Oncology, Joseph A. Impellizeri DVM, DACVIM (Oncology), MRCVS (Veterinary Oncology Services, New York, USA)
  • 13.00 Lunch

Session 4 - Evolving topics in Veterinary Immunotherapy
Chairperson: Joseph A. Impellizeri

  • 14.00 Cancer Immunotherapy: Helping Snoopy to help Charlie Brown, Luigi Aurisicchio (VITARES, Rome, Italy)
  • 14.40 Veterinary Oncology: a Nurses’ Perspective, Elisa Sanchez Strauss BS, LVT, CMT,ESMT (Veterinary Oncology Services, New York, USA)
  • 15.00 CSPG4 Hybrid plasmid-based vaccines for comparative oncology studies, Federica Cavallo (University of Turin, Italy)
  • 15.40 Electroporation: a 2019 Update on Electrochemotherapy and Electrogenetransfer – the U.S. Veterinary Experience, Joseph A. Impellizeri DVM, DACVIM (Oncology), MRCVS (Veterinary Oncology Services, New York, USA)
  • 16.20 CAR-T cells for dogs, Nicola Mason (VetPenn, Philadelphia, USA) via Skype
  • 17,00 Development of a RSV Vaccine, Alessandra Vitelli (Reithera, Rome)
  • 17.30 Multiplex approaches for Veterinary applications: optimizing turnaround time, costs and sample, Carlo Colombo (Prodotti Gianni, Milano)
  • 17.45 Plaisant, evoluzione di un’azienda, dalla stabulazione al sostegno della ricerca biomedica, Laura Tatangelo (Plaisant, Roma)
  • 18.00 End of Day 2

Final Program

Day 3 March 1st, 2019

Session 5 - Trends in Human Immunotherapy
Chairperson: Gennaro Ciliberto

  • 9.00 Towards precision immunotherapy, Gennaro Ciliberto (Istituto Regina Elena, Roma, Italy)
  • 9.30 Deciphering the tumor microenvironment in the new era of Immuno -Oncology, Paola Nisticò (Istituto Regina Elena, Roma)
  • 10.00 Diagnostic tools in Veterinary Oncology, Francesca Millanta (University of Pisa, Italy)
  • 10.30 Coffee Break
  • 11.00 Targeting the Cell  Cycle machinery, Antonio Giordano (Temple University and SBHRO, Philadelphia, USA)
  • 11.30 Immunotherapy for Melanoma: present and future, Antonio Grimaldi (Istituto Tumori Pascale, Napoli, Italy)
  • 12.00 Personalised Cancer Vaccines: HEPAVAC and beyond, Luigi Buonaguro (Istituto Tumori Pascale, Napoli, Italy)
  • 12.30 Immunoscore: predictive response and clinical relevance, Giosuè Scognamiglio (Istituto Tumori Pascale, Napoli, Italy)
  • 12.45 Closing remarks, Luigi Aurisicchio
  • 13.00 Lunch

Venue

The congress will be held at the Conference Room c / o Tecnopolo - Building A (Third Floor) - Via Castel Romano, 100 - 00128 Rome

Registration Fees

Online registrations are now open.

The registration fee includes entry to all scientific sessions, coffee breaks and lunches. For security and logistic purposes, participants must wear the badge visibly at all times during the congress.

Participation fee
• Free for Staff and VITARES members in good standing
120,0 60,00 Euro for the other participants

Registration Form and Abstract Submission

Download the application form, fill out and send a scanned copy to Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.. A confirmation will be sent as soon as the document and payment have been received by VITARES. Deadline for the online registration is February 22, 2019. On site registration will be possible only after previous authorization.

Abstracts for Poster presentations can be sent before February 22, 2019 to the mail: Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.. Acceptance for presentation will be notified on February 25, 2019.

Download form
Veterinary Immunotherapy and Translational Research

Contatti

  • E-Mail:

    Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.

  • Veterinary Immunotherapy and Translational Research
  • C.F. 97903190581

Policy

VITARES
© Copyright 2019
Tutti i diritti riservati.